DOI: 10.1055/s-00000175

Arzneimittelforschung

References

Ravandi F, O’Brien S, Thomas D et al.
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.

Blood 2010;
116: 2070-2077

Download Bibliographical Data

Search in:
Access: